期刊文献+

蛋白磷酸酶C1-TEN在急性髓系白血病细胞中的表达及抑制FLT3-ITD对其表达的影响 被引量:1

The expression of protein phosphatase C1-TEN in acute myeloid leukemia cells and inhibition of FLT3-ITD on its expression
下载PDF
导出
摘要 目的:本研究旨在揭示急性髓系白血病(AML)细胞中具有C1结构域并与TENsin同源的蛋白磷酸酶(C1-TEN)的表达情况,并探讨中间串联重复突变FMS样酪氨酸激酶3(FLT3-ITD)抑制条件下C1-TEN的表达水平。方法:利用酪氨酸激酶抑制剂(TKI)索拉菲尼、米朵妥林作用于AML细胞系HL-60细胞、MV4-11细胞,采用MTT实验评价AML细胞对TKI的敏感性;TKI对AML细胞FLT3活化作用及对C1-TEN表达的影响采用Western blot(WB)分析;CCK-8实验分析C1-TEN抑制对AML细胞活性的影响;WB、流式(FACS)检测细胞凋亡情况。结果:相比FLT3野生型(FLT3-WT)HL-60细胞,FLT3-ITD突变MV4-11细胞对TKI显著敏感(P<0.05)。WB结果显示,经TKI作用后MV4-11细胞的酪氨酸激酶FLT3活化较HL-60细胞显著下降(P<0.05)。与阴性对照组比较,TKI处理组MV4-11细胞C1-TEN表达显著下降,而HL-60细胞的变化不明显。C1-TEN抑制剂DHTS作用后,MV4-11细胞活性显著下降(P<0.05),且DHTS与TKI具有协同抑制作用。WB、FACS结果显示,DHTS处理组MV4-11细胞凋亡显著高于阴性对照,差异具有统计学意义(P<0.05)。结论:本研究首次报道AML细胞C1-TEN表达情况,揭示FLT3-ITD能上调AML细胞C1-TEN表达,而抑制C1-TEN可通过细胞凋亡机制杀伤FLT3-ITD突变的AML细胞,因此提示该蛋白磷酸酶可能是FLT3-ITD下游分子,有望成为AML治疗的新靶点。 Objective:The aim of this study was to reveal the expression of C1 domain-containing phosphatase and TENsin homologue(C1-TEN)in acute myeloid leukemia(AML)cells,and to investigate the expression level of C1-TEN under the inhibition of FMS-like tyrosine kinase 3 internal tandem duplication(FLT3-ITD).Methods:AML cell lines HL-60 cells and MV4-11 cells were treated with tyrosine kinase inhibitors(TKI)Sorafenib and middotropin,and the sensitivity of AML cells to TKI was evaluated by MTT assay.The effects of TKI on FLT3 activation and C1-TEN expression in AML cells were analyzed by Western blot(WB).The effect of C1-TEN inhibition on AML cell activity was analyzed by CCK-8 assay.WB and FACS were used to detect cell apoptosis.Results:Compared with FLT3 wild-type(FLT3-WT)HL-60 cells,FlT3-ITD mutant MV4-11 cells were significantly sensitive to TKI(P<0.05).The results of WB showed that the activation of tyrosine kinase FLT3 in MV4-11 cells after TKI treatment was significantly decreased compared with that in HL-60 cells(P<0.05).Compared with the negative control group,the expression of C1-TEN in MV4-11 cells decreased significantly in TKI treatment group,while the change in HL-60 cells was not obvious.After the treatment of C1-TEN inhibitor DHTS,the activity of MV4-11 cells was significantly decreased(P<0.05),and DHTS and TKI had synergistic inhibitory effect.The results of WB and FACS showed that the apoptosis of MV4-11 cells in DHTS treatment group was significantly higher than that in negative control group,the difference was statistically significant(P<0.05).Conclusion:The expression of C1-TEN in AML cells was reported by this study for the first time,revealing that FLT3-ITD can up-regulate the expression of C1-TEN in AML cells,while inhibition of C1-TEN can kill FLT3-ITD mutant AML cells through apoptosis mechanism.It was suggested that this protein phosphatase may be the downstream molecule of FLT3-ITD,expecting to be a new target for the treatment of AML.
作者 罗满生 赖旭旺 邓晓玲 曾艳梅 LUO Mansheng;LAI Xuwang;DENG Xiaoling;ZENG Yanmei(Clinical Laboratory,The Affiliated Ganzhou Hospital of Nanchang University,Ganzhou 341000,Jiangxi,China;The Second Clinical College of Medicine,Department of Medicine,Nanchang University,Nanchang 330006,Jiangxi,China;The Central Laboratory,The Affiliated Ganzhou Hospital of Nanchang University,Ganzhou 341000,Jiangxi,China)
出处 《暨南大学学报(自然科学与医学版)》 CAS CSCD 北大核心 2022年第6期595-602,共8页 Journal of Jinan University(Natural Science & Medicine Edition)
基金 江西省自然科学基金项目(20202BAB206064) 江西省卫生健康委员会科技计划项目(20202080) 赣州市科技局创新人才计划项目【赣市科发(2020)60号】。
关键词 急性髓系白血病(AML) FMS样酪氨酸激酶3(FLT3) 中间串联重复突变(ITD) 含有C1结构域并与TENsin同源的蛋白磷酸酶(C1-TEN) acute myeloid leukemia(AML) FMS-like tyrosine kinase 3(FLT3) internal tandem duplication(ITD) C1 domain-containing phosphatase and TENsin homologue(C1-TEN)
  • 相关文献

参考文献2

二级参考文献49

  • 1陈思,李扬秋,陈少华,杨力建,吴秀丽,岑东芝.急性髓细胞性白血病病人TCRζ链基因表达特点[J].循证医学,2007,7(1):54-57. 被引量:7
  • 2李扬秋,林晨,李蒲.T细胞受体的研究和应用[M]∥陈思,李扬秋.TCRξ隧基因分析的意义和应用.北京:人民卫生出版社,2009:183-185.
  • 3JUANG Y T, TENBROCK K, NAMBIAR M P, et al. Defective production of functional 98-kDa form of Elf-1 is responsible for the decreased exPression of TCR zetachain in patients with systemic lupus erythematosus [ J ]. Immunol, 2002, 169(10) : 6048 -6055.
  • 4TAKAI N, MIYAZAKI T, NISHIDA M, et al. The significance of Elf-1 expression in epithelial ovarian carcinoma[J]. Int J Mol Med, 2003, 12(3) : 349 -354.
  • 5TAKAI N, MIYAZAKI T, NISHIDA M, et al. Clinical relevance of Elf-1 overexpression in endometrial carcinoma[J]. Gyne Onc, 2003, 89(3) : 408 -413.
  • 6STAMS W A G, den BOER M L, BEVERLOO H B, et al. Sensitivity to L-as-paraginase is not associated with expression levels of asparagine syn-thetase in t (12; 21)^+ pediatric ALL[J]. Blood, 2003, 101(7) : 2743 - 2747.
  • 7LIVAK K J, SCHMI33YGEN T D. Analysis of relative gene expression data using real-time quantitative PCR and the 2^-△△Ct Method [ J]. Methods, 2001, 25 (4): 402- 408.
  • 8RELLAHAN B L, JENSEN J P, HOWCROFT T K, et al. Elf-1 regulates basal expression from the T cell anti- gen receptor ζ-chain gene promoter[ J]. Immunol, 1998, 160(6) : 2794-2801.
  • 9JUANG Y T, SUMIBCAY L, TOLNAY M, et al. Elf-1 binds to GGAA elements on the FcRgamma promoter and represses its expression [ J ]. Immunol, 2007, 179 (7) : 4884 - 4889.
  • 10TAKAHASHI K, HAYASHI N, SHIMOKAWA T. Cooperative regulation of Fc receptor gamma-chain gene expression by multiple transcription factors, including Spl, GABP, and Elf-1 [J]. Biol Chem, 2008, 283 (22) : 15134 - 15141.

共引文献6

同被引文献27

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部